Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Encompass Health (DE:HSOA)
BERLIN:HSOA
Encompass Health (HSOA) Stock Price & Analysis
0 Followers
HSOA Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€54.52 - €77.00
Previous Close€74.5
Volume0.00
Average Volume (3M)8.00
Market Cap
€7.55B
Enterprise Value€10.95B
Total Cash (Recent Filing)$99.70M
Total Debt (Recent Filing)$2.93B
Price to Earnings (P/E)N/A
Beta0.33
Next Earnings
Apr 24, 2024EPS Estimate
€0.88Last Dividend Ex-Date
Mar 28, 2024Dividend Yield0.73%
Share Statistics
EPS (TTM)N/A
Shares Outstanding100,140,031
10 Day Avg. Volume0
30 Day Avg. Volume8
Standard Deviation0.06
R-Squared0.07
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)91.41
Price to Sales (P/S)1.50
Price to Cash Flow (P/CF)10.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.64
Enterprise Value/Gross Profit2.49
Enterprise Value/Ebitda14.50
Forecast
1Y Price Target
€82.16Price Target Upside10.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Encompass Health News
PremiumCompany Announcements
Encompass Health Clarifies Financial Reporting and 2024 Costs
Bulls Say, Bears Say
Bulls Say
Financial PerformanceEHC's strong performance in Q4, marked by solid same-store growth and effective labor cost management, highlights the company's robust financial health.
Operational EfficiencyImprovements in registered nurse turnover and contract labor expenses demonstrate EHC's increasing operational efficiency and stable cost structure.
Regulatory EnvironmentThe absence of the home health transfer payment policy in the CMS's proposed rate update is a positive sign for EHC, suggesting a favorable regulatory environment.
Bears Say
Cost ManagementLabor conditions are improving, however, the company anticipates labor costs to grow at a faster rate than previously expected.
Financial GuidanceThe company's guidance for 2024 EBITDA is only slightly improved, indicating concerns over labor costs stability and an increase in denovo losses compared to the previous year.
ProfitabilityProfit margins are expected to decline by 50 basis points year-over-year due to start-up losses which are projected to be significantly higher than in the previous year.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
4.31% Other Institutional Investors
95.69% Public Companies and
Individual Investors
HSOA FAQ
What was Encompass Health’s price range in the past 12 months?
Encompass Health lowest stock price was €54.52 and its highest was €77.00 in the past 12 months.
What is Encompass Health’s market cap?
Currently, no data Available
When is Encompass Health’s upcoming earnings report date?
Encompass Health’s upcoming earnings report date is Apr 24, 2024 which is today.
How were Encompass Health’s earnings last quarter?
Encompass Health released its earnings results on Feb 07, 2024. The company reported €0.891 earnings per share for the quarter, beating the consensus estimate of €0.765 by €0.126.
Is Encompass Health overvalued?
According to Wall Street analysts Encompass Health’s price is currently Undervalued.
Does Encompass Health pay dividends?
Encompass Health pays a Quarterly dividend of €0.14 which represents an annual dividend yield of 0.73%. See more information on Encompass Health dividends here
What is Encompass Health’s EPS estimate?
Encompass Health’s EPS estimate is €0.88.
How many shares outstanding does Encompass Health have?
Currently, no data Available
What happened to Encompass Health’s price movement after its last earnings report?
Encompass Health reported an EPS of €0.891 in its last earnings report, beating expectations of €0.765. Following the earnings report the stock price went up 0.752%.
Which hedge fund is a major shareholder of Encompass Health?
Among the largest hedge funds holding Encompass Health’s share is Clough Capital Partners L P. It holds Encompass Health’s shares valued at 11M.
---
Encompass Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€82.16 (10.28% Upside)
€82.16 (10.28% Upside)
Blogger Sentiment
Bullish
DE:HSOA Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.24%
12-Months-Change
Fundamentals
Return on Equity
24.53%
Trailing 12-Months
Asset Growth
8.27%
Trailing 12-Months
Company Description
Encompass Health
Encompass Health Corp. engages in providing post-acute healthcare services. It operates through the following segments: Inpatient Rehabilitation and Home Health & Hospice. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac & pulmonary conditions, brain & spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
---
HSOA Company Deck
---
HSOA Earnings Call
Q4 2024
0:00 / 0:00
---
HSOA Stock 12 Months Forecast
Average Price Target
€82.16
▲(10.28% Upside)
Technical Analysis
Encompass Health
―
HCA Healthcare
―
Universal Health
―
Tenet Healthcare
―
Community Health
―
Best Analysts Covering HSOA
1 Year
1 Year Success Rate
24/27 ratings generated profit
1 Year Average Return
+23.66%
reiterated a buy rating 9 days ago
Copying David S Macdonald's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +23.66% per trade.
---